Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS (CHANGE-MS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02782858 |
|
Recruitment Status :
Completed
First Posted : May 25, 2016
Last Update Posted : October 20, 2020
|
Sponsor:
GeNeuro SA
Collaborators:
Les Laboratoires Servier (LLS)
Institut de Recherches Internationales Servier
Worldwide Clinical Trials
Information provided by (Responsible Party):
GeNeuro SA
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | August 2017 |
| Actual Study Completion Date : | December 2017 |